RISK FACTORS AND GASTRIC DISEASE IN PEDIATRIC H PYLORI

儿科幽门螺杆菌的危险因素和胃病

基本信息

  • 批准号:
    2796618
  • 负责人:
  • 金额:
    $ 21.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-09-30 至 2002-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (taken from the application) Helicobacter pylori (Hp) is the major cause world-wide of chronic-active gastritis, primary duodenal ulcers, and is linked to gastric cancer. Most Hp infections are acquired in childhood; why some individuals develop symptomatic disease and others do not is unclear. Histopathological studies suggest that the degree and type of inflammatory infiltrate in gastroduodenal lesions are significantly different in Hp-infected children compared to adults. However, these differences remain unexplained. Studies of the host immune response following initial Hp infection in childhood and the relationship to Hp virulence factors (i.e., vacA) bolstered by the evaluation of host risk factors for infection are critical to understand the pathogenesis of Hp infection. Our preliminary studies of Hp infection in children developed accurate non-invasive methods for detection of infection and showed a unique gastric mucosal inflammatory response with increased numbers of macrophages. In vitro, we demonstrated the impotence of IL-8 and RANTES chemokines for leukocyte activation and recruitment. Furthermore, we demonstrated a difference in the T-cell responses of Hp-infected versus uninfected patients. Overall hypothesis: among Hp infected children, there are host factors (i.e., ethnicity) and environmental cofactors (i.e., water source) which result in symptomatic disease and children with symptoms will be infected by virulent Hp strains and have a more significant mucosal inflammatory response. Specific aims: 1) determine the host factors and environmental cofactors necessary for symptomatic Hp infection in children. Hp-infected symptomatic endoscopy cases at 4 centers will be compared to age, gender and region-matched Hp-infected asymptomatic controls. 2) characterize the bacterial properties (i.e., phenotype, genotype) associated with pediatric Hp infection. The phenotype and genotype prevalence of Hp isolates obtained from infected cases will be evaluated in comparison to gastroduodenal disease severity. 3) characterize the host inflammatory response of Hp-infected children. The histopathology in comparison to the chemokine and cellular response in the gastric mucosa of infected children will be determined. The proposed research provides a systematic examination of the association between Hp strains and host exposure characteristics and the severity of clinical disease in children. These studies are prerequisite for understanding the host-bacterial interaction in initial infection and evolution of gastroduodenal inflammation and overall pathogenesis of Hp.
描述(取自应用程序) 幽门螺杆菌(Helicobacter pylori,Hp)是世界范围内慢性活动性胃炎的主要病因 胃炎,原发性十二指肠溃疡,并与胃癌有关。最 Hp感染是在儿童时期获得的;为什么有些人会发展 有症状的疾病和其他不清楚。组织病理学研究 表明,炎症浸润的程度和类型, 幽门螺杆菌感染儿童胃十二指肠病变有显著差异 与成年人相比。然而,这些差异仍然无法解释。研究 儿童期初始Hp感染后的宿主免疫反应, 与Hp毒力因子的关系(即,vacA), 评估宿主感染的风险因素对于了解 Hp感染的发病机制。我们对幽门螺杆菌感染的初步研究 儿童发展出准确的非侵入性方法来检测感染 并显示出独特的胃粘膜炎症反应, 巨噬细胞的数量在体外实验中,我们证明了IL-8和 用于白细胞活化和募集的RANTES趋化因子。而且我们 证实了Hp感染者与 未感染的患者总体假设:在Hp感染儿童中, 是宿主因素(即,种族)和环境辅因子(即,水 源),导致症状性疾病,有症状的儿童将 被强毒Hp菌株感染,并具有更显著的粘膜 炎症反应。具体目标:1)确定宿主因素, 儿童症状性Hp感染所必需的环境辅助因子 将比较4个中心的Hp感染症状性内镜检查病例, 年龄、性别和地区匹配的Hp感染无症状对照。(二) 表征细菌特性(即,表型,基因型)相关 儿童幽门螺杆菌感染幽门螺杆菌的表型和基因型 将对从感染病例中获得的分离株进行评价, 胃十二指肠疾病严重程度。3)表征宿主炎症 Hp感染儿童的反应。组织病理学与 感染儿童胃粘膜中趋化因子和细胞反应 将被确定。拟议的研究提供了一个系统的检查 Hp菌株与宿主暴露特征之间的关联, 儿童临床疾病的严重程度。这些研究 了解宿主-细菌相互作用的先决条件 感染和胃十二指肠炎症演变以及总体 幽门螺杆菌的致病机制

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BENJAMIN David GOLD其他文献

BENJAMIN David GOLD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BENJAMIN David GOLD', 18)}}的其他基金

Role of Infectious Agents in Pediatric Crohn's Disease
传染源在小儿克罗恩病中的作用
  • 批准号:
    6824565
  • 财政年份:
    2004
  • 资助金额:
    $ 21.76万
  • 项目类别:
Role of Infectious Agents in Pediatric Crohn's Disease
传染源在小儿克罗恩病中的作用
  • 批准号:
    6931945
  • 财政年份:
    2004
  • 资助金额:
    $ 21.76万
  • 项目类别:
RISK FACTORS AND GASTRIC DISEASE IN PEDIATRIC H PYLORI
儿科幽门螺杆菌的危险因素和胃病
  • 批准号:
    6177576
  • 财政年份:
    1997
  • 资助金额:
    $ 21.76万
  • 项目类别:
RISK FACTORS AND GASTRIC DISEASE IN PEDIATRIC H PYLORI
儿科幽门螺杆菌的危险因素和胃病
  • 批准号:
    2906175
  • 财政年份:
    1997
  • 资助金额:
    $ 21.76万
  • 项目类别:
Risk factors for gastric disease in pediatric H. pylori
儿童幽门螺杆菌胃病的危险因素
  • 批准号:
    7067999
  • 财政年份:
    1997
  • 资助金额:
    $ 21.76万
  • 项目类别:
Risk factors for gastric disease in pediatric H. pylori
儿童幽门螺杆菌胃病的危险因素
  • 批准号:
    6778813
  • 财政年份:
    1997
  • 资助金额:
    $ 21.76万
  • 项目类别:
RISK FACTORS AND GASTRIC DISEASE IN PEDIATRIC H PYLORI
儿科幽门螺杆菌的危险因素和胃病
  • 批准号:
    2540775
  • 财政年份:
    1997
  • 资助金额:
    $ 21.76万
  • 项目类别:
RISK FACTORS AND GASTRIC DISEASE IN PEDIATRIC H PYLORI
儿科幽门螺杆菌的危险因素和胃病
  • 批准号:
    6381096
  • 财政年份:
    1997
  • 资助金额:
    $ 21.76万
  • 项目类别:
Risk factors for gastric disease in pediatric H. pylori
儿童幽门螺杆菌胃病的危险因素
  • 批准号:
    6943174
  • 财政年份:
    1997
  • 资助金额:
    $ 21.76万
  • 项目类别:
Risk factors for gastric disease in pediatric H. pylori
儿童幽门螺杆菌胃病的危险因素
  • 批准号:
    7067023
  • 财政年份:
    1997
  • 资助金额:
    $ 21.76万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 21.76万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 21.76万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 21.76万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 21.76万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 21.76万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 21.76万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 21.76万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 21.76万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 21.76万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 21.76万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了